AI in Medical Imaging market projected to reach USD 20,082.1 million by 2033

Metastat Insights has published "Global AI in Medical Imaging Market Size, Share, By Imaging Modality (Computed Tomography (CT), Magnetic Resonance Imaging (MRI), X-rays, Mammography and Digital Breast Tomosynthesis, Ultrasound, Nuclear Medicine Imaging (PET and SPECT), Others (Fluoroscopy and Specialty Imaging)), By Deployment Model (Cloud-Based, On-Premises and Hybrid), By Clinical Application (Neurology and Stroke, Oncology, Pulmonary and Chest Imaging, Musculoskeletal Imaging, Breast Imaging, Cardiology and Cardiovascular Imaging, Abdominal Imaging, Emergency and Trauma Imaging, Others (Pediatric and Other Specialty Imaging)), By End User (Hospitals and Health Systems, Independent Diagnostic Imaging Centers, Radiology and Teleradiology Service Providers, Specialty Clinics and Ambulatory Care Centers, Others (Research Institutions and Clinical Trial Imaging Sites)), Industry Analysis, Growth, Trends, and Forecast, 2026-2033", followed by the headline figures (USD 1,809.1 million in 2025, USD 20,082.1 million by 2033, 35.1% CAGR).

What is driving AI in Medical Imaging demand

Demand for the AI in Medical Imaging market is significantly influenced by ongoing digital transformation efforts within healthcare systems. Increased investments in technology integration enhance operational capabilities and streamline processes. Healthcare providers adopt digital solutions to improve diagnostic accuracy, which supports patient care. The aging population generates a higher demand for advanced imaging technologies, because older demographics typically experience more chronic conditions requiring early diagnosis. This growing emphasis on early detection and precise imaging drives the adoption of AI solutions in various clinical settings.

What is holding back the market

Regulatory hurdles present significant challenges for the AI in Medical Imaging market, impacting the swift adoption of AI solutions. Compliance with complex regulations regarding medical data privacy and security requires substantial investments in technology and human resources. These requirements often strain operational budgets and delay the implementation of advanced imaging technologies. Macroeconomic pressures, including inflation, further limit the financial resources available for investment in AI technologies. Organizations face additional constraints from supply chain disruptions and geopolitical factors, which hinder the timely deployment of innovative imaging solutions.

Market segmentation analysis

The AI in Medical Imaging market is segmented by imaging modality, deployment model, clinical application, and end user. By imaging modality, the market encompasses segments including Computed Tomography (CT), Magnetic Resonance Imaging (MRI), X-ray technologies, mammography and digital breast tomosynthesis, ultrasound, and nuclear medicine imaging, including PET and SPECT. The cloud-based deployment model is projected to exhibit the highest growth, reaching USD 11,605.4 million by 2033. The neurology and stroke clinical application segment is expected to grow significantly, driven by the increasing prevalence of neurological disorders and the need for enhanced diagnostic tools.

Key players in the AI in Medical Imaging market

Companies operating in the AI in Medical Imaging market include DeepHealth, Inc., Aidoc, Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., FUJIFILM Corporation, Qure.ai Technologies Private Limited, and others. These organizations adapt their portfolios to include a diverse range of AI-driven imaging solutions, focusing on innovative applications and collaborations that enhance their offerings. The competitive positioning within the market has evolved significantly, with key players investing in research and development to strengthen their market presence and address the growing demand for sophisticated medical imaging technologies.

For more detailed insights, visit the full report: Global AI in Medical Imaging Market.